Browsing by Author Chen L.-T.

Jump to:
0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Showing results 192 to 203 of 203 < previous

Issue Date	Title	Author(s)	Source	scopus	WOS	Fulltext/Archive link
2011	T(11;18)(q21;q21) translocation as predictive marker for non-responsiveness to salvage thalidomide therapy in patients with marginal zone B-cell lymphoma with gastric involvement	Kuo S.-H.; Cheng A.-L.; Lin C.-W.; CHIH-HUNG HSU ; Wu M.-S.; Yeh K.-H.; Tzeng Y.-S.; Chen L.-T.	Cancer Chemotherapy and Pharmacology	10	4
2011	T(11;18)(q21;q21) translocation as predictive marker for non-responsiveness to salvage thalidomide therapy in patients with marginal zone B-cell lymphoma with gastric involvement	Kuo S.-H.; Cheng A.-L.; CHUNG-WU LIN ; Hsu C.-H.; Wu M.-S.; Yeh K.-H.; Tzeng Y.-S.; Chen L.-T.	Cancer Chemotherapy and Pharmacology	10	4
2011	T(11;18)(q21;q21) translocation as predictive marker for non-responsiveness to salvage thalidomide therapy in patients with marginal zone B-cell lymphoma with gastric involvement	Kuo S.-H.; Cheng A.-L.; Lin C.-W.; Hsu C.-H.; Wu M.-S.; KUN-HUEI YEH ; Tzeng Y.-S.; Chen L.-T.	Cancer Chemotherapy and Pharmacology
2011	T(11;18)(q21;q21) translocation as predictive marker for non-responsiveness to salvage thalidomide therapy in patients with marginal zone B-cell lymphoma with gastric involvement	Kuo S.-H.; Cheng A.-L.; Lin C.-W.; Hsu C.-H.; MING-SHIANG WU ; Yeh K.-H.; Tzeng Y.-S.; Chen L.-T.	Cancer Chemotherapy and Pharmacology		4
2011	T(11;18)(q21;q21) translocation as predictive marker for non-responsiveness to salvage thalidomide therapy in patients with marginal zone B-cell lymphoma with gastric involvement	SUNG-HSIN KUO ; Cheng A.-L.; Lin C.-W.; Hsu C.-H.; Wu M.-S.; Yeh K.-H.; Tzeng Y.-S.; Chen L.-T.	Cancer Chemotherapy and Pharmacology
2020	Two first-in-human studies of xentuzumab, a humanised insulin-like growth factor (IGF)-neutralising antibody, in patients with advanced solid tumours	de Bono J.; Lin C.-C.; Chen L.-T.; Corral J.; Michalarea V.; Rihawi K.; Ong M.; Lee J.-H.; CHIH-HUNG HSU ; Yang J.C.-H.; Shiah H.-S.; Yen C.-J.; Anthoney A.; Jove M.; Buschke S.; Fuertig R.; Schmid U.; Goeldner R.-G.; Strelkowa N.; Huang D.C.-L.; Bogenrieder T.; Twelves C.; Cheng A.-L.	British Journal of Cancer	0	3
2010	Unusual presentation of multiple pathologic bone fractures in a patient with gastric mucosa-associated lymphoid tissue lymphoma	Kuo S.-H.; Yen R.-F.; CHUNG-WU LIN ; Chen L.-T.; Tien H.F.; Cheng A.-L.	Annals of Hematology	1	1
2010	Unusual presentation of multiple pathologic bone fractures in a patient with gastric mucosa-associated lymphoid tissue lymphoma	Kuo S.-H.; RUOH-FANG YEN ; Lin C.-W.; Chen L.-T.; Tien H.F.; Cheng A.-L.	Annals of Hematology		1
2010	Unusual presentation of multiple pathologic bone fractures in a patient with gastric mucosa-associated lymphoid tissue lymphoma	Kuo S.-H.; Yen R.-F.; Lin C.-W.; Chen L.-T.; HWEI-FANG TIEN ; Cheng A.-L.	Annals of Hematology		1
2010	Unusual presentation of multiple pathologic bone fractures in a patient with gastric mucosa-associated lymphoid tissue lymphoma	SUNG-HSIN KUO ; Yen R.-F.; Lin C.-W.; Chen L.-T.; Tien H.F.; Cheng A.-L.	Annals of Hematology
1997	Weekly 24-hour infusion of high-dose 5-fluorouracil and leucovorin in the treatment of advanced gastric cancers	CHIH-HUNG HSU ; Yeh K.-H.; Chen L.-T.; Liu J.M.; Jan C.-M.; Lin J.-T.; Chen Y.-C.; Cheng A.-L.	Oncology (Switzerland)	60	51
1997	Weekly 24-hour infusion of high-dose 5-fluorouracil and leucovorin in the treatment of advanced gastric cancers	Hsu C.-H.; KUN-HUEI YEH ; Chen L.-T.; Liu J.M.; Jan C.-M.; Lin J.-T.; Chen Y.-C.; Cheng A.-L.	Oncology (Switzerland)

Showing results 192 to 203 of 203 < previous